文献速递冠心病外科

多支冠状动脉病变:冠状动脉旁路移植与经皮血运重建的比较

Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease.
PubMed 文献 · Ann Thorac Surg · 2019-05-02

该倾向匹配回顾性观察分析纳入2010至2018年因多支冠状动脉病变行CABG或PCI且有全国登记数据的患者,匹配后每组844例;结果示PCI相对CABG的全因死亡风险比为1.64(95%CI 1.29–2.10,p<0.001),再入院与再次血运重建风险亦更高,主要临床亚组结果一致 favoring CABG。

要点

  • 匹配队列中PCI相对CABG死亡风险比为1.64(95%CI 1.29–2.10,p<0.001)。
  • PCI相对CABG再入院风险比1.42、再次血运重建风险比4.06,均p<0.001。
  • 主要心血管不良事件及各项结局在几乎所有主要临床亚组中均倾向于CABG。

核心结论

  • 在多支冠状动脉病变患者中,CABG较PCI带来显著的生存获益,且该获益在几乎所有主要患者亚组中一致。

研究设计与样本

  • 倾向匹配回顾性观察分析,初始6163例多支冠状动脉病变患者,匹配后CABG与PCI各844例。
  • 纳入2010至2018年行CABG或PCI、且数据可于国家心血管数据注册或胸外科医师学会成人心脏外科数据库获取的患者。
  • 主要结局为总生存,次要结局包括免于住院再入院和免于再次血运重建。

主要发现

  • 估计1年死亡率在PCI组为11.5%、CABG组为7.2%(p<0.001)。
  • PCI相对CABG的总体死亡风险比为1.64(95%CI 1.29–2.10;p<0.001)。
  • PCI相对CABG的再入院总体风险比为1.42(95%CI 1.23–1.64;p<0.001)。
  • PCI相对CABG的再次血运重建总体风险比为4.06(95%CI 2.39–6.91;p<0.001)。
  • 总体主要不良心血管事件及死亡、再入院、再次血运重建各项结局在几乎所有主要临床亚组中均倾向于CABG。

临床怎么用

  • 面向多支冠状动脉病变患者进行血运重建决策与知情同意讨论时,可将CABG的生存及免于再入院、免于再次血运重建优势纳入共享决策。

局限性

  • 为倾向匹配回顾性观察分析,非随机对照,可能存在未测量混杂。
  • 作者指出尚需反映常规实践的未来研究,以评估多支冠状动脉病变患者血运重建的共享决策与知情同意方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study focused on contemporary outcomes after coronary artery bypass graft (CABG) surgery versus percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease (MVCAD). METHODS: This was a propensity-matched retrospective, observational analysis. Patients with MVCAD who underwent CABG or PCI between 2010 and 2018 and for whom data were available through the National Cardiovascular Data Registry or The Society of Thoracic Surgeons Adult Cardiac Surgery Database were included. The primary outcome was overall survival. Secondary outcomes included freedom from inpatient readmission and freedom from repeat revascularization. RESULTS: Of the initial 6,163 patients with MVCAD, the propensity-matched cohort included 844 in each group. The estimated 1-year mortality was 11.5% and 7.2% (p < 0.001) in the PCI and CABG groups, respectively, with an overall hazard ratio for mortality of PCI versus CABG of 1.64 (95% confidence interval [CI], 1.29 to 2.10; p < 0.001). The overall hazard ratio for readmission for PCI versus CABG was 1.42 (95% CI, 1.23 to 1.64; p < 0.001). The overall hazard ratio for repeat revascularization for PCI versus CABG was 4.06 (95% CI, 2.39 to 6.91; p < 0.001). Overall major adverse cardiovascular events and individual outcomes of mortality, readmission, and repeat revascularization all favored CABG across virtually all major clinical subgroups. CONCLUSIONS: This contemporary propensity-matched analysis of patients undergoing coronary revascularization for MVCAD demonstrates a significant mortality benefit with CABG over PCI, and this benefit is consistent across virtually all major patient subgroups. Futures studies are needed reflecting routine practice to assess how best to approach shared decision making and informed consent when it comes to revascularization decisions in any patient with MVCAD.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Mulukutla SR, Gleason TG, Sharbaugh M, et al. Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease. Ann Thorac Surg. 2019. PMID: 31056197. doi:10.1016/j.athoracsur.2019.02.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。